XML 172 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Investments
9 Months Ended
Oct. 31, 2014
Investments Schedule [Abstract]  
Investments
Investments
Marketable Securities
At October 31, 2014, marketable securities consisted of the following (in thousands):
 
Investments classified as Marketable Securities
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
Corporate notes and obligations
$
596,671

 
$
2,186

 
$
(439
)
 
$
598,418

U.S. treasury securities
56,563

 
94

 
(28
)
 
56,629

Mortgage backed obligations
46,629

 
192

 
(302
)
 
46,519

Asset backed securities
125,599

 
88

 
(43
)
 
125,644

Municipal securities
38,976

 
38

 
(79
)
 
38,935

Foreign government obligations
20,031

 
309

 
0

 
20,340

U.S. agency obligations
17,987

 
12

 
(16
)
 
17,983

Covered bonds
75,089

 
1,395

 
0

 
76,484

Total marketable securities
$
977,545


$
4,314


$
(907
)

$
980,952

At January 31, 2014, marketable securities consisted of the following (in thousands):
 
Investments classified as Marketable Securities
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
Corporate notes and obligations
$
340,706

 
$
1,314

 
$
(170
)
 
$
341,850

U.S. treasury securities
16,016

 
28

 
0

 
16,044

Mortgage backed obligations
24,888

 
281

 
(93
)
 
25,076

Asset backed securities
38,213

 
39

 
(35
)
 
38,217

Municipal securities
2,000

 
1

 
(3
)
 
1,998

Foreign government obligations
24,305

 
171

 
(2
)
 
24,474

U.S. agency obligations
14,726

 
9

 
(10
)
 
14,725

Covered bonds
76,282

 
717

 
(1
)
 
76,998

Total marketable securities
$
537,136


$
2,560


$
(314
)

$
539,382


The duration of the investments classified as marketable securities is as follows (in thousands):
 
 
As of
 
October 31,
2014
 
January 31,
2014
Recorded as follows:
 
 
 
Short-term (due in one year or less)
$
79,779

 
$
57,139

Long-term (due after one year)
901,173

 
482,243

 
$
980,952

 
$
539,382


As of October 31, 2014, the following marketable securities were in an unrealized loss position (in thousands):
 
 
Less than 12 Months
 
12 Months or Greater
 
Total
 
Fair Value
 
Unrealized
Losses
 
Fair Value
 
Unrealized
Losses
 
Fair Value
 
Unrealized
Losses
Corporate notes and obligations
$
206,762

 
$
(410
)
 
$
3,276

 
$
(29
)
 
$
210,038

 
$
(439
)
U.S. treasury securities
25,671

 
(28
)
 
0

 
0

 
25,671

 
(28
)
Mortgage backed obligations
30,652

 
(281
)
 
1,399

 
(21
)
 
32,051

 
(302
)
Asset backed securities
45,589

 
(38
)
 
2,357

 
(5
)
 
47,946

 
(43
)
Municipal securities
22,391

 
(79
)
 
0

 
0

 
22,391

 
(79
)
U.S. agency obligations
9,980

 
(16
)
 
0

 
0

 
9,980

 
(16
)
 
$
341,045

 
$
(852
)
 
$
7,032

 
$
(55
)
 
$
348,077

 
$
(907
)

The unrealized loss for each of these fixed rate marketable securities ranged from less than $1,000 to $44,000. The Company does not believe any of the unrealized losses represent an other-than-temporary impairment based on its evaluation of available evidence as of October 31, 2014. The Company expects to receive the full principal and interest on all of these marketable securities.
Fair Value Measurement
All of the Company’s cash equivalents, marketable securities and foreign currency derivative contracts are classified within Level 1 or Level 2 because the Company’s cash equivalents, marketable securities and foreign currency derivative contracts are valued using quoted market prices or alternative pricing sources and models utilizing observable market inputs. The Company's restricted cash balance of $114.9 million at October 31, 2014 was held in a money market account and is not included in the following table.
The Company uses a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:
 
Level 1.    Quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2.    Other inputs that are directly or indirectly observable in the marketplace.

Level 3.    Unobservable inputs which are supported by little or no market activity.

The following table presents information about the Company’s assets and liabilities that are measured at fair value as of October 31, 2014 and indicates the fair value hierarchy of the valuation (in thousands):
 
Description
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
 
Significant  Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Balances as of
October 31, 2014
Cash equivalents (1):
 
 
 
 
 
 
 
Time deposits
$
0

 
$
129,590

 
$
0

 
$
129,590

Money market mutual funds
40,368

 
0

 
0

 
40,368

Marketable securities:
 
 
 
 
 
 
 
Corporate notes and obligations
0

 
598,418

 
0

 
598,418

U.S. treasury securities
0

 
56,629

 
0

 
56,629

Mortgage backed obligations
0

 
46,519

 
0

 
46,519

Asset backed securities
0

 
125,644

 
0

 
125,644

Municipal securities
0

 
38,935

 
0

 
38,935

Foreign government obligations
0

 
20,340

 
0

 
20,340

U.S. agency obligations
0

 
17,983

 
0

 
17,983

Covered bonds
0

 
76,484

 
0

 
76,484

Foreign currency derivative contracts (2)
0

 
667

 
0

 
667

Total Assets
$
40,368

 
$
1,111,209

 
$
0

 
$
1,151,577

Liabilities
 
 
 
 
 
 
 
Foreign currency derivative contracts (3)
$
0

 
$
1,558

 
$
0

 
$
1,558

Total Liabilities
$
0

 
$
1,558

 
$
0

 
$
1,558

_____________ 
(1)Included in “cash and cash equivalents” in the accompanying condensed consolidated balance sheet as of October 31, 2014, in addition to $676.4 million of cash.
(2)Included in “prepaid expenses and other current assets” in the accompanying condensed consolidated balance sheet as of October 31, 2014.
(3)Included in “accounts payable, accrued expenses and other liabilities” in the condensed consolidated balance sheet as of October 31, 2014.
The following table presents information about the Company’s assets and liabilities that are measured at fair value as of January 31, 2014 and indicates the fair value hierarchy of the valuation (in thousands):
 
Description
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
 
Significant Other
Observable Inputs (Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Balances as of
January 31, 2014
Cash equivalents (1):
 
 
 
 
 
 
 
Time deposits
$
0

 
$
212,700

 
$
0

 
$
212,700

Money market mutual funds
87,898

 
0

 
0

 
87,898

Marketable securities:
 
 
 
 
 
 
 
Corporate notes and obligations
0

 
341,850

 
0

 
341,850

U.S. treasury securities
0

 
16,044

 
0

 
16,044

Mortgage backed obligations
0

 
25,076

 
0

 
25,076

Asset backed securities
0

 
38,217

 
0

 
38,217

Municipal securities
0

 
1,998

 
0

 
1,998

Foreign government obligations
0

 
24,474

 
0

 
24,474

U.S. agency obligations
0

 
14,725

 
0

 
14,725

Covered bonds
0

 
76,998

 
0

 
76,998

Foreign currency derivative contracts (2)
0

 
1,598

 
0

 
1,598

Total Assets
$
87,898

 
$
753,680

 
$
0

 
$
841,578

Liabilities
 
 
 
 
 
 
 
Foreign currency derivative contracts (3)
$
0

 
$
1,801

 
$
0

 
$
1,801

Total Liabilities
$
0

 
$
1,801

 
$
0

 
$
1,801

______________ 
(1)Included in “cash and cash equivalents” in the accompanying condensed consolidated balance sheet as of January 31, 2014, in addition to $481.0 million of cash.
(2)Included in “prepaid expenses and other current assets” in the accompanying condensed consolidated balance sheet as of January 31, 2014.
(3)Included in “accounts payable, accrued expenses and other liabilities” in the accompanying condensed consolidated balance sheet as of January 31, 2014.
Derivative Financial Instruments
The Company enters into foreign currency derivative contracts with financial institutions to reduce the risk that its cash flows and earnings will be adversely affected by foreign currency exchange rate fluctuations. The Company uses forward currency derivative contracts to minimize the Company’s exposure to balances primarily denominated in Euros, Japanese yen, Canadian dollars and British pounds. The Company’s foreign currency derivative contracts, which are not designated as hedging instruments, are used to reduce the exchange rate risk associated primarily with intercompany receivables and payables. The Company’s derivative financial instruments program is not designated for trading or speculative purposes. As of October 31, 2014 and January 31, 2014, the foreign currency derivative contracts that were not settled were recorded at fair value on the condensed consolidated balance sheets.
Foreign currency derivative contracts are marked-to-market at the end of each reporting period with gains and losses recognized as other expense to offset the gains or losses resulting from the settlement or remeasurement of the underlying foreign currency denominated receivables and payables. While the contract or notional amount is often used to express the volume of foreign currency derivative contracts, the amounts potentially subject to credit risk are generally limited to the amounts, if any, by which the counterparties’ obligations under the agreements exceed the obligations of the Company to the counterparties.
Details on outstanding foreign currency derivative contracts related primarily to intercompany receivables and payables are presented below (in thousands):
 
 
As of
 
October 31,
2014
 
January 31,
2014
Notional amount of foreign currency derivative contracts
$
661,238

 
$
563,060

Fair value of foreign currency derivative contracts
$
(891
)
 
$
(203
)


The fair value of the Company’s outstanding derivative instruments are summarized below (in thousands):
 
 
 
Fair Value of Derivative Instruments
 
 
As of
  
Balance Sheet Location
October 31, 2014
 
January 31, 2014
Derivative Assets
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
Foreign currency derivative contracts
Prepaid expenses and other current assets
$
667

 
$
1,598

Derivative Liabilities
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
Foreign currency derivative contracts
Accounts payable, accrued expenses and other liabilities
$
1,558

 
$
1,801



The effect of the derivative instruments not designated as hedging instruments on the condensed consolidated statements of operations during the three and nine months ended October 31, 2014 and 2013, respectively, are summarized below (in thousands):
 
Derivatives Not Designated as Hedging Instruments
Gains (Losses) on Derivative Instruments
Recognized in Income
 
 
 
Three Months Ended 
 October 31,
 
Location
 
2014
 
2013
Foreign currency derivative contracts
Other expense
 
$
(3,068
)
 
$
4,523

 
 
 
 
 
 
Derivatives Not Designated as Hedging Instruments
Gains (Losses) on Derivative Instruments
Recognized in Income
  
 
 
Nine Months Ended 
 October 31,
 
Location
 
2014
 
2013
Foreign currency derivative contracts
Other expense
 
$
(2,964
)
 
$
2,468


Strategic Investments
The Company has three investments in marketable equity securities measured using quoted prices in their respective active markets and certain interests in non-marketable equity and debt securities that are collectively considered strategic investments. As of October 31, 2014, the fair value of the Company’s marketable equity securities of $11.2 million includes an unrealized gain of $9.3 million. As of January 31, 2014, the Company had three investments in marketable equity securities that had a fair value of $15.5 million, which included an unrealized gain of $13.3 million. These investments are recorded at fair value in other assets, net on the condensed consolidated balance sheets.
The Company’s interest in non-marketable equity and debt securities consists of noncontrolling equity and debt investments in privately-held companies. The Company’s investments in these privately-held companies are reported at cost or marked down to fair value when an event or circumstance indicates an other-than-temporary decline in value has occurred. These investments are valued using significant unobservable inputs or data in an inactive market and the valuation requires the Company’s judgment due to the absence of market prices and inherent lack of liquidity.
As of October 31, 2014 and January 31, 2014, the carrying value of the Company’s investments in privately-held companies was $121.0 million and $77.0 million, respectively. These investments are recorded in other assets, net on the condensed consolidated balance sheets. The estimated fair value of the Company's investments in privately-held companies was $230.0 million as of October 31, 2014.
Investment Income
Investment income consists of interest income, realized gains, and realized losses on the Company’s cash, cash equivalents and marketable securities. The components of investment income are presented below (in thousands):
 
 
Three Months Ended 
 October 31,
 
Nine Months Ended 
 October 31,
 
2014
 
2013
 
2014
 
2013
Interest income
$
2,720

 
$
1,258

 
$
7,051

 
$
8,029

Realized gains
78

 
332

 
424

 
5,732

Realized losses
(176
)
 
(480
)
 
(420
)
 
(4,910
)
Total investment income
$
2,622

 
$
1,110


$
7,055

 
$
8,851


Reclassification adjustments out of accumulated other comprehensive loss into net income (loss) were immaterial for the three and nine months ended October 31, 2014 and 2013.